Real Clients. Real Results.

Inflation Reduction Act Federal And State Policy Market Access

Case Study: Turning IRA Policy into Portfolio and Pricing Strategy 

State Policy Federal And State Policy

Case Study: Rare Disease State Policy Engagement

Inflation Reduction Act Pharmaceuticals and Biotech Federal And State Policy Strategic Analytics, Value and Economics

Case Study: Medicare Part D Liability Model 

Inflation Reduction Act Federal And State Policy

Case Study: Strengthening Positioning for IRA Drug Price Negotiation

Cell and Gene Strategic Analytics, Value and Economics

Case Study: Medicare Utilization and Cost Trends for CAR-T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma

Cell and Gene Pharmaceuticals and Biotech Market Access

Case Study: Parkinson’s Cell and Gene Therapy: Commercialization Strategy Workshop

Cell and Gene Pharmaceuticals and Biotech Market Access

CMMI Engagement on CGT Model

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Oncology/biologics Federal And State Policy

Case Study: Demystifying the Evolving Policy Landscape for Oncology

Inflation Reduction Act Federal And State Policy

Case Study: Navigating the Inflation Reduction Act

Devices Devices Reimbursement

Case Study: Reimbursement Strategy for Lifesaving Cervical Dilator

Oncology/biologics Pharmaceuticals and Biotech Strategic Analytics, Value and Economics

Case Study: Assessing PD-1/PD-L1 Usage in the Enhancing Oncology Model

Devices Market Access

Case Study: Product Ideation and Commercialization Strategies